Acceleron Pharma Inc.
ACTRIIB BINDING AGENTS AND USES THEREOF
Last updated:
Abstract:
The disclosure provides, among other aspects, neutralizing antibodies and portions thereof that bind to ActRIIB and uses for same.
Status:
Application
Type:
Utility
Filling date:
30 Apr 2021
Issue date:
31 Mar 2022